Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Laxatives Market Portraiture
2.2. Global Laxatives Market, by Drug Type, 2017 (US$ Mn)
2.3. Global Laxatives Market, by Geography, 2017 (US$ Mn)
Chapter 3. Laxatives Market Analysis
3.1. Laxatives Market Overview
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Lifestyle Trends Increase the Risk of Constipation thus Consumption of Laxatives
3.2.1.2. Higher Prevalence of Constipation in Geriatric Population
3.2.2. Challenges
3.2.2.1. Demographic Reservations to Impact the Market
3.2.3. Opportunities
3.2.3.1. Emerging Markets Present Lucrative Opportunity for Growth
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Laxatives Market, by Drug Type, 2016-2026 (US$ Mn)
4.1. Preface
4.1.1. Attractive Investment Proposition, by Drug Type, 2017
4.2. Senna
4.3. Bisacodyl
4.4. Docusate
4.5. Polyethylene Glycol 3350
4.6. Psyllium
4.7. Methylcellulose
4.8. Others
4.9. Phase Analysis (Market estimations by 2026)
4.9.1. Projected Sale of Phase III Drugs Estimated Till 2026 (US$ Mn)
4.9.1.1. BLI801
4.9.1.2. AJG555
4.9.1.3. Elobixibat
4.9.1.4. Tenapanor
4.9.2. Qualitative Information on Phase II and I drugs
Chapter 5. Global Laxatives Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. North America Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.2.1. North America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.3.1. Europe Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.4.1. Asia Pacific Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Latin America Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.5.1. Latin America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) Laxatives Market Analysis, 2016 – 2026 (US$ Mn)
5.6.1. MEA Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Bayer AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Application Portfolio
6.1.4. Key Developments
6.2. Boehringer Ingelheim Pharmaceuticals, Inc.
6.3. Braintree Laboratories, Inc.
6.4. GlaxoSmithKline Consumer Healthcare, L.P.
6.5. Procter & Gamble Company
6.6. Purdue Pharma L.P.
6.7. Sucampo Pharmaceuticals, Inc.
List Of Figures
FIG. 1 Laxatives Market: Research Methodology
FIG. 2 Global Laxatives Market, by Drug Type, 2017 (US$ Mn)
FIG. 3 Global Laxatives Market, by Geography, 2017 (US$ Mn)
FIG. 4 Attractive Investment Proposition, by Geography, 2017
FIG. 5 Market Competition Landscape, by Key Players, 2017
FIG. 6 Attractive Investment Proposition, by Drug Type, 2017
FIG. 7 Global Senna Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 8 Global Bisacodyl Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 9 Global Docusate Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 10 Global Polyethylene Glycol 3350 Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 11 Global Psyllium Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 12 Global Methylcellulose Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 13 Global Others Market for Laxatives, 2016 – 2026 (US$ Mn)
FIG. 14 Global BLI801 Market for Laxatives, till 2026 (US$ Mn)
FIG. 15 Global AJG555 Market for Laxatives, till 2026 (US$ Mn)
FIG. 16 Global Elobixibat Market for Laxatives, till 2026 (US$ Mn)
FIG. 17 Global Tenapanor Market for Laxatives, till 2026 (US$ Mn)
FIG. 18 U.S. Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 19 Canada Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 20 U.K. Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 21 Germany Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Europe Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 23 China Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 26 Brazil Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 27 Mexico Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Latin America Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 29 GCC Laxatives Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of Middle East and Africa Laxatives Market, 2016 – 2026 (US$ Mn)
List Of Table
TABLE 1 Global Laxatives Market Portraiture
TABLE 2 Global Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Pipeline Analysis Market for Laxatives, Till 2026 (US$ Mn)
TABLE 4 Global Laxatives Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 7 Europe Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America Laxatives Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa Laxatives Market, by Drug Type, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa Laxatives Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 15 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Boehringer Ingelheim Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Braintree Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Procter & Gamble Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Purdue Pharma L.P.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Sucampo Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)